Dr Lal PathLabs Q2 FY26 Profit Rises 16.4% to ₹152 Crore; Declares ₹7 Interim Dividend and 1:1 Bonus Issue

New Delhi, October 31, 2025: Dr Lal PathLabs Limited (NSE: LALPATHLAB, BSE: 539524) reported a robust set of financials for the quarter ended September 30, 2025, driven by consistent diagnostic demand and operational efficiency.

Financial Performance

Dr Lal PathLabs Limited announced a steady performance for the second quarter of FY26 as revenue and profitability improved on a year-on-year basis. In Q2 FY26, revenues for the July-September 2025 quarter were up 10.7% at ₹731 crore as against ₹660 crore in the same quarter a year ago.

The operating performance continued to stay strong, with EBITDA increasing 10.8% to ₹224 crore, while margins were maintained at 30.7%, reflecting efficient cost management. Net profit (PAT) for the quarter stood at ₹152 crore, up 16.4% year-on-year, supported by stable revenue growth and margin. The PAT margin improved to 20.8% from 19.8% in Q2 FY25.

EPS rose 16.2% over last year to ₹18.1 against ₹15.5 in the same quarter of the previous year. In the first half of FY26, the diagnostics major reported revenue of ₹1,400 crore, a rise of 11% over last year, while net profit rose 20% to ₹286 crore, underlining consistent performance across regions and test categories.

Dividend and Bonus Issue

The board declared an interim dividend of ₹7 per share for Q2 FY26. It also approved a 1:1 bonus issue, meaning the shareholders will get one bonus share for every share held on the record date.

Share Price Update

At 3:10 PM, the share price of Dr Lal PathLabs traded at ₹ 3,125, up 1.15% on Friday. The stock opened at ₹3,089.90 and hit an intraday high of ₹3,208.90, while the day’s low stood at ₹3,063.00 in the latest trade.

The company’s market capitalization stands at ₹26,080 crore and is trading at a P/E ratio of 50.74. The stock yields a dividend yield of 0.77% with a quarterly dividend payout of ₹6.02 per share. During the last year, the stock has oscillated between a high of ₹3,540 and a low of ₹2,293.55 within the past 52 weeks.

REF: https://nsearchives.nseindia.com/corporate/LALPATHLAB_31102025143333_FINALpressRelease.pdf

Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations